Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging partnerships and a robust ...
Focused on immunology-based therapies for infectious diseases, this biotech company reported a notable insider sale in recent ...
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ('the Company', 'Kraig Labs', or 'Kraig's'), a world leader in spider silk ...
Vir Biotechnology has a cash runway into 2028 and pivotal 2026 catalysts for its lead hepatitis drugs. Learn why VIR stock is ...
Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...
From the early days of the Manhattan Project to the race to develop artificial intelligence, America has long recognized that being at the forefront of emerging technologies is critical to our ...
The biotechnology instruments market is growing due to personalized medicine, genomics, and molecular diagnostics.
Is VIR a good stock to buy? We came across a bullish thesis on Vir Biotechnology, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on VIR. Vir Biotechnology, ...
Launched with NSF funding this year, Penn’s AIRFoundry boasts the potential to radically speed up drug development.
"We anticipate dosing the first patient in the combination dose expansion cohorts in both early-line MCRPC and metastatic hormone-sensitive prostate cancer over the coming months." (President, CEO & ...
The Chosun Ilbo on MSN
China leads US in critical technology patents, data shows
China has been confirmed to quantitatively overwhelm the U.S. in the latest international patents for “critical and emerging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results